Humacyte, Inc. Files Material Definitive Agreement 8-K
Ticker: HUMAW · Form: 8-K · Filed: Mar 26, 2025 · CIK: 1818382
| Field | Detail |
|---|---|
| Company | Humacyte, Inc. (HUMAW) |
| Form Type | 8-K |
| Filed Date | Mar 26, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-action
Related Tickers: HUMA
TL;DR
Humacyte signed a big deal, filing an 8-K today.
AI Summary
On March 25, 2025, Humacyte, Inc. filed an 8-K report detailing a material definitive agreement. The company, previously known as Alpha Healthcare Acquisition Corp., is incorporated in Delaware and operates in the biological products sector.
Why It Matters
This filing indicates a significant new contract or partnership for Humacyte, Inc., which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, making the immediate impact uncertain.
Key Players & Entities
- Humacyte, Inc. (company) — Registrant
- Alpha Healthcare Acquisition Corp. (company) — Former company name
- March 25, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement filed by Humacyte, Inc.?
The filing does not specify the details of the material definitive agreement, only that one has been entered into.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on March 25, 2025.
What was Humacyte, Inc.'s former company name?
Humacyte, Inc.'s former company name was Alpha Healthcare Acquisition Corp.
In which state is Humacyte, Inc. incorporated?
Humacyte, Inc. is incorporated in Delaware.
What is Humacyte, Inc.'s Standard Industrial Classification code?
Humacyte, Inc.'s Standard Industrial Classification code is 2836, for Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 26, 2025 regarding Humacyte, Inc. (HUMAW).